Andy Olson, MBA, co-founded Inherent Biosciences with a vision to pioneer a new category of diagnostics and therapeutics that leverage epigenetics to radically transform how we diagnose and treat complex diseases. After watching friends struggle with a frustrating diagnosis of unexplained infertility, he felt compelled to use his 20 years of experience in commercializing molecular, DNA-based diagnostics to help those searching for new answers. Previously, Andy has led the commercialization of healthcare products in five separate start-ups, taking four of them through successful exits.  He has also contributed to successful FDA 510k submissions and has led efforts to establish new CPT codes and reimbursement determinations for novel molecular diagnostic tests.  Andy holds a Bachelors of Science in molecular biology from Brigham Young University and an MBA from the University of Houston’s C.T. Bauer College of Business. He enjoys spending time with his family, skiing, cycling, and competing in the LOTOJA 200-plus-mile road bike race from Logan, Utah, to Jackson Hole, Wyoming, that is completed in one day.